1Nagy HJ, Panis Y, Fabre M, et al. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene[J]. Anticancer Res, 2000, 20(6B):4633-4638.
2Sandalon Z, Fusening NE, McCutcheon J, et al. Suicide gene therapy for premalignant disease: a new strategy for the treatment of intraepithelial neoplasia[J]. Gene Ther, 2001, 8(3):232-238.
3Trudeau C, Yuan S, Galipeau J, et al. A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells[J]. Hum Gene Ther, 2001, 12(13):1673-1680.
4Karle P, Renner M, Salmon B, et al. Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide[J]. Cancer gene Ther, 2001, 8(3):220-230.
5Miki K, Xu M, Gupta A, et al. Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate[J]. Cancer Res, 2001, 61(18):6805-6810.
6Nagy HJ, Panis Y, Fabre M, et al. Efficient suicide gene therapy of transduced and distant untransduced ovary tumors is correlated with significant increase of intratumoral T and NK cells[J]. Biomed Pharmacother, 2000, 54(10):479-486.
7Agard C, Ligeza c, Dupas B, et al. Immune-dependent distant bystander effct after abenovirus mediated suicide gene transfer in a rat model of liver colorectal metastasis[J]. Cancer Gene Ther, 2001, 8(2):128-136.
8Jones RK, Pope IM, Kinsella AR, et al. Combined suicide granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity[J]. Cancer Gener Ther, 2000, 7(12):1519-1528.
